CHAPEL HILL, N.C.--(BUSINESS WIRE)--Feb. 26, 2014--
POZEN Inc. (NASDAQ: POZN), a pharmaceutical company
committed to transforming medicine that transforms lives, announced
today that it plans to release fourth quarter and year end 2013 results
on March 5, 2014, before the market opens.
The announcement will be followed by a live webcast at 11:00 a.m. (ET)
with a discussion by POZEN management of the earnings and business
results. The webcast can be accessed on POZEN’s website at www.pozen.com
and will be archived and available for replay. The fourth quarter and
year end 2013 earnings release will be accessible in the Media section
of POZEN’s website.
POZEN Inc. is a small pharmaceutical company that specializes in
developing novel therapeutics for unmet medical needs and licensing
those products to other pharmaceutical companies for commercialization.
By utilizing a unique in-source model and focusing on integrated
therapies, POZEN has successfully developed and obtained FDA approval of
two self-invented products in two years. Funded by these
milestones/royalty streams, POZEN is creating a portfolio of
cost-effective, evidence-based integrated aspirin therapies designed to
enable the full power of aspirin by reducing its GI damage.
POZEN is currently seeking ex-U.S. strategic partners to help maximize
the opportunities for its portfolio assets.
The Company's common stock is traded under the symbol “POZN” on The
NASDAQ Global Market. For more detailed company information, including
copies of this and other press releases, please visit www.pozen.com.
Source: POZEN Inc.
Bill Hodges, Chief Financial Officer
Manager, Investor Relations & Public Relations